These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 35217816)

  • 1. The role of REV-ERB in NASH.
    Griffett K; Hayes ME; Boeckman MP; Burris TP
    Acta Pharmacol Sin; 2022 May; 43(5):1133-1140. PubMed ID: 35217816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of transcriptional control by Rev-erbα: An energetic foundation for reconciling structure and binding with biological function.
    Vaissière A; Berger S; Harrus D; Dacquet C; Le Maire A; Boutin JA; Ferry G; Royer CA
    Protein Sci; 2015 Jul; 24(7):1129-46. PubMed ID: 25969949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. REV-ERBα and REV-ERBβ function as key factors regulating Mammalian Circadian Output.
    Ikeda R; Tsuchiya Y; Koike N; Umemura Y; Inokawa H; Ono R; Inoue M; Sasawaki Y; Grieten T; Okubo N; Ikoma K; Fujiwara H; Kubo T; Yagita K
    Sci Rep; 2019 Jul; 9(1):10171. PubMed ID: 31308426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between circadian oscillations of Rev-erbalpha expression and intracellular levels of its ligand, heme.
    Rogers PM; Ying L; Burris TP
    Biochem Biophys Res Commun; 2008 Apr; 368(4):955-8. PubMed ID: 18280802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta.
    Raghuram S; Stayrook KR; Huang P; Rogers PM; Nosie AK; McClure DB; Burris LL; Khorasanizadeh S; Burris TP; Rastinejad F
    Nat Struct Mol Biol; 2007 Dec; 14(12):1207-13. PubMed ID: 18037887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for rev-erbα ligands in regulation of adipogenesis.
    Kojetin DJ; Burris TP
    Curr Pharm Des; 2011; 17(4):320-4. PubMed ID: 21375499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of synthetic agonist activation of the nuclear receptor REV-ERB.
    Murray MH; Valfort AC; Koelblen T; Ronin C; Ciesielski F; Chatterjee A; Veerakanellore GB; Elgendy B; Walker JK; Hegazy L; Burris TP
    Nat Commun; 2022 Nov; 13(1):7131. PubMed ID: 36414641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear hormone receptors for heme: REV-ERBalpha and REV-ERBbeta are ligand-regulated components of the mammalian clock.
    Burris TP
    Mol Endocrinol; 2008 Jul; 22(7):1509-20. PubMed ID: 18218725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structural basis of gas-responsive transcription by the human nuclear hormone receptor REV-ERBbeta.
    Pardee KI; Xu X; Reinking J; Schuetz A; Dong A; Liu S; Zhang R; Tiefenbach J; Lajoie G; Plotnikov AN; Botchkarev A; Krause HM; Edwards A
    PLoS Biol; 2009 Feb; 7(2):e43. PubMed ID: 19243223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The REV-ERB Nuclear Receptors: Timekeepers for the Core Clock Period and Metabolism.
    Adlanmerini M; Lazar MA
    Endocrinology; 2023 Apr; 164(6):. PubMed ID: 37149727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of REV-ERBβ ligand-binding domain bound to a porphyrin antagonist.
    Matta-Camacho E; Banerjee S; Hughes TS; Solt LA; Wang Y; Burris TP; Kojetin DJ
    J Biol Chem; 2014 Jul; 289(29):20054-66. PubMed ID: 24872411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcriptional repressor REV-ERB as a novel target for disease.
    Uriz-Huarte A; Date A; Ang H; Ali S; Brady HJM; Fuchter MJ
    Bioorg Med Chem Lett; 2020 Sep; 30(17):127395. PubMed ID: 32738989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Affinity Heme Binding to a Heme Regulatory Motif on the Nuclear Receptor Rev-erbβ Leads to Its Degradation and Indirectly Regulates Its Interaction with Nuclear Receptor Corepressor.
    Carter EL; Gupta N; Ragsdale SW
    J Biol Chem; 2016 Jan; 291(5):2196-222. PubMed ID: 26670607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A specific and unusual nuclear localization signal in the DNA binding domain of the Rev-erb orphan receptors.
    Chopin-Delannoy S; Thénot S; Delaunay F; Buisine E; Begue A; Duterque-Coquillaud M; Laudet V
    J Mol Endocrinol; 2003 Apr; 30(2):197-211. PubMed ID: 12683943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of adipogenesis by natural and synthetic REV-ERB ligands.
    Kumar N; Solt LA; Wang Y; Rogers PM; Bhattacharyya G; Kamenecka TM; Stayrook KR; Crumbley C; Floyd ZE; Gimble JM; Griffin PR; Burris TP
    Endocrinology; 2010 Jul; 151(7):3015-25. PubMed ID: 20427485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. REV-ERB agonism improves liver pathology in a mouse model of NASH.
    Griffett K; Bedia-Diaz G; Elgendy B; Burris TP
    PLoS One; 2020; 15(10):e0236000. PubMed ID: 33002003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redundant function of REV-ERBalpha and beta and non-essential role for Bmal1 cycling in transcriptional regulation of intracellular circadian rhythms.
    Liu AC; Tran HG; Zhang EE; Priest AA; Welsh DK; Kay SA
    PLoS Genet; 2008 Feb; 4(2):e1000023. PubMed ID: 18454201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of SR8278, a synthetic antagonist of the nuclear heme receptor REV-ERB.
    Kojetin D; Wang Y; Kamenecka TM; Burris TP
    ACS Chem Biol; 2011 Feb; 6(2):131-4. PubMed ID: 21043485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. REV-ERB agonism suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss partially via FABP4 upregulation.
    Song C; Tan P; Zhang Z; Wu W; Dong Y; Zhao L; Liu H; Guan H; Li F
    FASEB J; 2018 Jun; 32(6):3215-3228. PubMed ID: 29401617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of the nuclear receptor REV-ERBα linked with circadian oscillators in the expressions of Alas1, Ppargc1a, and Il6 genes in rat granulosa cells.
    Chen H; Isayama K; Kumazawa M; Zhao L; Yamauchi N; Shigeyoshi Y; Hashimoto S; Hattori MA
    Chronobiol Int; 2015; 32(6):739-49. PubMed ID: 26102301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.